Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NOVOZYMES BIOINDUSTRIAL CHINA A/S
A/S
Active
CVR 21599042
Krogshøjvej 36, 2880
Bagsværd
Activities of holding companies
· NACE 6421
Est. 1999
— employees
Watchlist
Share
Denmark
/
Companies
/
Activities of holding companies
/
NOVOZYMES BIOINDUSTRIAL CHINA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LK
Lisbet Kragelund
Management
Management
2024
Former (6)
BD
Benny Dalgaard Loft
Chief Executive Officer
Chief Executive Officer
2013 – 2016
PA
Per Artur Fredrik Månsson
Chief Executive Officer
Chief Executive Officer
2000 – 2006
RC
Randi Camilla Kinch Jensen
Chief Executive Officer
Chief Executive Officer
2016 – 2024
PA
Peter Andreas Stakemann
Management
Management
1999 – 1999
PH
Peder Holk Nielsen
Chief Executive Officer
Chief Executive Officer
2010 – 2013
KA
Kurt Anker Nielsen
Chief Executive Officer
Chief Executive Officer
1999 – 2000
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RC
Rainer Chapour Lehmann
Board of Directors
2023
MV
Mikkel Viltoft
Chairman
2010
Former (10)
MØ
Mads Øvlisen
Chairman
1999 – 2000
AH
Annemette Heller
Board of Directors
1999 – 1999
KM
Kristian Merser
Chairman
2007 – 2010
TV
Thomas Videbæk
Board of Directors
2007 – 2010
AP
Andrew Patrick Fordyce
Board of Directors
2013 – 2021
OF
Ole Falvig Ramsby
Board of Directors
1999 – 2000
LG
Lars Green
Board of Directors
2021 – 2023
KM
Kim Madsen
Board of Directors
1999 – 1999
TS
Tina Sejersgård Fanø
Board of Directors
2017 – 2021
SR
Steen Riisgaard
Chairman
2000 – 2007
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NOVOZYMES A/S
Company
100%
100%
2000
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NOVOZYMES BIOINDUSTRIAL CHINA A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network